Delcath Systems Inc (DCTH)

[Tekterra]

Look at this one. This is a read out of the phase III of the Melanoma Liver Metastases comparing the Chemosat treatment to best available care.

PFS was 7 months compare to best available care of 1.6 months. Although OS was not significantly longer it proved as effective treatment to stabilize the cancer and prevent progression for far longer period of time.

The conclusion was that the trial had demonstrated significantly improved hPFS, oPFS, and hOR. And that's comparing to best of care available.

So when people tell me Delcath is going to be sold for 17 million dollars, I would say you're crazy. Or I'd be completely shocked if it ever happen.


https://www.ncbi.nlm.nih.gov/pubmed/26597368